Phthalimide–benzoic acid hybrids as potent aldose reductase inhibitors: Synthesis, enzymatic kinetics, and in silico characterization
Top Cited Papers
- 27 September 2025
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 131, 118416
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Carbonic anhydrase inhibition by antiviral drugs in vitro and in silicoJournal of Molecular Recognition, 2023
- Phthalimide as a versatile pharmacophore scaffold: Unlocking its diverse biological activitiesDrug Development Research, 2023
- Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4‐hydroxy‐3,5‐dimethoxy benzaldehyde motifArchiv der Pharmazie, 2022
- In Vitro Inhibitory Activity and Molecular Docking Study of Selected Natural Phenolic Compounds as AR and SDH Inhibitors**ChemistrySelect, 2022
- N‐substituted phthalazine sulfonamide derivatives as non‐classical aldose reductase inhibitorsJournal of Molecular Recognition, 2022
- Naphthoquinones, benzoquinones, and anthraquinones: Molecular docking, ADME and inhibition studies on human serum paraoxonase‐1 associated with cardiovascular diseasesDrug Development Research, 2020
- Jaguar: A high‐performance quantum chemistry software program with strengths in life and materials sciencesInternational Journal of Quantum Chemistry, 2013
- Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected DiseasesChemMedChem, 2008
- Epik: a software program for pK a prediction and protonation state generation for drug-like moleculesJournal of Computer-Aided Molecular Design, 2007
- A hierarchical approach to all‐atom protein loop predictionProteins: Structure, Function, and Bioinformatics, 2004